NorthWest Biotherapeutics Inc (NWBO)

[ilovetech]

Hope, NWBO'S NYAS presentation was far richer as a soft release, than the more generalized release, which Amarin did over a call that weekend in September. The public had to wait for the full "embargoed" data release dictated by the NEJM. The journal released the electronic version at the same time the lead investigator was presenting during the AHA conference.

NWBO is facing the same embargo restrictions Amarin had to contend with. But IMO, Amarin's study was far more straight forward, and likely far easier to submit and publish within a favorable time frame. The DCVAX trial was very complex. You can't throw the Reduce-it trial in the same basket. We don't know why the journal is taking so long. One thing I can say with utmost confidence, it can't be anything NWBO has control over. I'd hate to be in D. Innes's shoe's. The pressure and frustration must be crazy.

ILT